Member Info for nomlungu

https://github.com/bitshares/bitshares-core/wiki/theoretical-theories

KIE does not work in my models.

I am being cautious whilst the Brexit uncertainty lasts.

Troajan,

I am expecting Tissue Regenix to drop to around 3p whilst the Woodford uncertainty lasts.

I know more about this company than most and hope to ride the inevitable spike.

Another share I like but am out of - the July trading statement is likely to be brutal.

The US mid-west has been unable to plant because of the flooding. The Chinese do not want the agricultural products because of the trade wars; and now the Chinese have put in place over 60 percent tariffs on Pig imports so demand for feed in the US is declining.

Another AIM crash coming?

Just 2 percent down today but the 2 small sells in the afternoon had to accept under the Bid.

If you cannot sell 115 000 shares at the Bid what happens when Woodford wants to sell 300 million shares? The Market Makers do not want them.

TRX is not part of the AIM 50 Index so cannot be traded on the Turquoise trading platform - the dark pool will not help.

Thanks - I am not a FT subscriber so never read what you are alluding to.

The Placing RNS dared 17 May stated 'The Placing was significantly oversubscribed'.

Where do you get the information that it was '3x oversubsribed' from?

Another new approach that might leave PHE with outdated tech:

https://www.thedailybeast.com/how-to-convert-earths-plastic-pandemic-into-fuel?ref=home

Trading at 40 percent discount to NAV...

8.125 / 0.6 = 13.54 p is the approximate NAV. The current SP is a bargain and JV's comments just remind me to watch out for any silly drop in share price.

The July update on the drilling being undertaken by Ascendant should give an indication of the likelihood of them completing the drilling which will result in the milestone payment to MAFL.

look at the link

https://www.valirx.com/aim-rule-26/shares-issue/

nobody has declared that holding

Which of 'Woodfords unlisted dogs' address PD-1?

https://www.abcam.com/cancer/tools-for-immuno-oncology-biomarker-research?

Shape theory is complicated...

http://www.180degreecapital.com/

Another £ hedge but more complicated by the diverse portfolio.

I think Woodford will have to sell their holding - you should be able to read the tea leaves from the links below.

https://www.morningstar.co.uk/uk/news/AN_1560847727337015100/oakley-capital-directors-step-in-to-buy-as-woodford-sells-12-stake-(alliss).aspx

https://www.theguardian.com/business/2019/jun/18/fidelity-woodford-income-focus-fund-neil-woodford

https://www.tissueregenixus.com/investors/shareholder-centre/advisors-and-shareholders/

Tissue Regenix need to find a new institutional investor to buy Woodford's shares - imo dyor etc

I do not understand - can you explain how this phrase works with the valuation of Valirx's compounds. Destruction of solid tumours?

Permeation is the penetration of a permeate through a solid. It is directly related to the concentration gradient of the permeate, a material's intrinsic permeability, and the materials' mass diffusivity.

#imbuing

Abcam are on the look out for acquisitions - £200m 3 year RCF put in place with another £100m as an 'accordion feature' and they have recently appointed Numis as a joint broker [even more money wanted?].

Free cash flow of £80m a year though; it is going to be interesting to see what they buy, especially as they are a Pound hedge.

If you have any interest in biotech / cancer research you should know about ABC - if not, do some more research.

And another 8 percent down today on fairly insignificant sells. Woodford has 300 million shares to sell. And they have to raise $5m.

I cannot see the bottom yet... Maybe another 40 percent to go?

Oops!

https://www.theguardian.com/business/2019/jun/18/fidelity-woodford-income-focus-fund-neil-woodford

I did a test buy with Best Invest and they offered 5p a share to buy - I had not expected to be able to buy at the Bid.

I use the UBlock extension on Chrome - you can use the 'Block Element' command to prevent the green banner from loading.

'So it is very much in the interests of the company that the SP is maximised in the short term...'

So the BOD can pay themselves wages?

CaveatEmptor = buyer beware

Down a few percent today... The Market Makers made a seller take below the Bid for less than £10k this morning on a lightly traded company with a MCAP of over £50m.

Despite being interesting in the science, it does not help when you say you need to raise funds - a strategic blunder which I hope to profit from.

The blood on the wall seems to foretold - meatpackers with boning knives are going to eviscerate this.